Patent · US Expired

Process for the synthesis of ribonucleotide reductase inhibitors 3-AP and 3-AMP

US5869676A · kind A · utility

4Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 15, 1997
Grant dateFeb 9, 1999
Priority date
Expiry dateMay 15, 2017

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to improved, efficient chemical syntheses of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and 3-amino-4-methylpyridine-2-carboxaldehyde thiosemicarbazone (3-AMP).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.